See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Cell Cycle

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
13828 3-Deazaneplanocin A 102052-95-9 ≥98% 2011-02-18 202.135919494870 3-deazaneplanocin-a DZNep; NSC 617989 EZH2 KMT6 methyltransferases histones cancer epigenetics panobinostat 3deazaneplanocin 3-cyclopentene-1,2-diol deriv Adenosine Adenocard 202.135919494870
10495 4-iodo-SAHA 1219807-87-0 ≥98% 2011-01-10 33.013491712707 4-iodo-saha anti-cancers HDACs inhibitors anti-proliferation 4-Hydroxy-5-iodo-3-nitrophenyl)acetyl 4-Hydroxy-3-iodo-5-nitrophenyl)acetyl 5-Iodo-4-hydroxy-3-nitrophenacetyl 5 Iodo 4 hydroxy 3 nitrophenacetyl Nitrohydroxyiodophenylacetate Hydroxyiodonitrophenylacetate Hapten NIP Acetyl Acetyl Hapten NIP NIP Acetyl Hapten NIP-Hapten NIP Hapten 33.013491712707
13145 AGK2 304896-28-4 ≥98% 2009-10-22 12.457375690607 agk2 sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration 12.457375690607
13123 BIO 667463-62-9 ≥98% 2009-06-09 29.315680562530 bio GSK 3 IX; MLS 2052 GSK-3α GSK-3β inhibitors Cdk cells cycle wnt ESCs differentiation embryonic stem GSK-3a/b GSK3a/b 29.315680562530
13299 Bisindolylmaleimide IV 119139-23-0 ≥98% 2009-07-29 9.348204419889 bisindolylmaleimide-iv Arcyriarubin A PKC PKA staurosporine inhibitors 634199-73-8 9.348204419889
13013 (−)-Blebbistatin 856925-71-8 ≥98% 2009-04-16 31.490644567218 -blebbistatin (S)-Blebbistatin inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light blebs (-)-(S)-Blebbistatin 31.490644567218
13165 (+)-Blebbistatin - ≥98% 2009-04-16 46.189613259668 -blebbistatin (R)-Blebbistatin inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light (+)-(R)-Blebbistatin inhibition inhibited 46.189613259668
13186 (±)-Blebbistatin 674289-55-5 ≥98% 2009-06-09 54.049226519337 -blebbistatin inhibitors muscles myosin ATPase smooth bleb apoptosis cells migration chemotaxis cytokinesis division growth UV lights 54.049226519337
13497 BRD4/HUNK1 Polyclonal Antibody - 2009-09-22 31.130985146304 brd4-hunk1-polyclonal-antibody BET antibodies WB western blots blotting immunoblotting terminus isoforms 31.130985146304
10007955 CAY10498 863202-33-9 >98% 2006-08-02 31.125340699815 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 31.125340699815
10008872 CAY10503 - >98% 2007-08-02 88.029171270718 cay10503 apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic 88.029171270718
10010301 CAY10554 267654-00-2 >95% 2007-12-01 8.577513812154 cay10554 BML-259 cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases 8.577513812154
10010043 CAY10561 Exclusive 933786-58-4 >98% 2008-03-06 29.675248618784 cay10561 Pyrazolylpyrrole ERK Inhibitor MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors 29.675248618784
10011247 CAY10574 140651-18-9 >95% 2008-09-04 12.328154696132 cay10574 CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 12.328154696132
10011256 CAY10577 300675-28-9 ≥95% 2008-09-02 0.867403314917 cay10577 inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers 0.867403314917
10011264 CAY10578 19231-60-8 ≥95% 2008-08-26 0.867403314917 cay10578 inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids 0.867403314917
13836 CAY10625 137346-42-0 ≥95% 2010-06-23 1.389314917127 cay10625 apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo 1.389314917127
10009349 Cell Cycle Phase Determination Kit - 2007-04-20 58.698116367403 cell-cycle-phase-determination-kit assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba 58.698116367403
10009853 CFSE Cell Division Assay Kit - 2010-01-15 60.126685082873 cfse-cell-division-assay-kit derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein 60.126685082873
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 3.357182320442 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 3.357182320442
10010706 (−)-Deguelin 522-17-8 ≥98% 2008-09-18 16.982430939227 -deguelin (-)-cis-Deguelin rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K 16.982430939227
10008422 D-myo-Inositol-1,5,6-triphosphate (sodium salt) 120965-76-6 ≥98% 2009-08-04 16.850451197053 d-myo-inositol-1-5-6-triphosphate-sodium-salt Ins(1,5,6)-P3 (sodium salt); 1,5,6-IP3 (sodium salt) phosphates IP2 signal transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositol IP3 second messengers trisphosphates PtdIns phosphatidylinositol D-myos PIPS 16.850451197053
10008419 D-myo-Inositol-2,4-diphosphate (sodium salt) - ≥98% 2009-08-04 19.335009208102 d-myo-inositol-2-4-diphosphate-sodium-salt Ins(2,4)-P2 (sodium salt); 2,4-IP2 (sodium salt) phosphates IP2 signals transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositols IP3 second messengers biphosphates bisphosphates PtsIns phosphatidylinositol 106358-02-5 19.335009208102
10010302 DRB 53-85-0 ≥98% 2008-01-21 3.046829666246 drb Benzimidazole; NSC 401575 cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat 3.046829666246
10924 Epothilone B 152044-54-7 ≥95% 2011-07-27 17.700165745856 epothilone-b macrolides inhibitors inhibits inhibition tubulin microtubules polymerization cancers cells cycle mitotic arrest mitosis Hs578T HeLa KB3-1 KB31 KBV-1 KBV1 cytoskeletal 17.700165745856
10007806 Epoxomicin 134381-21-8 ≥98% 2008-12-09 46.106121546961 epoxomicin BU 4061T inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors 46.106121546961
10010238 Erbstatin Analog 63177-57-1 ≥98% 2008-06-06 0.934806629835 erbstatin-analog Methyl 2,5-dihydoxycinnamate analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers 0.934806629835
13355 Geldanamycin 30562-34-6 ≥98% 2010-07-29 28.221732797588 geldanamycin NSC 122750 NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors 2,5-Cyclohexadiene-1,4-Diones 1,4-Benzoquinones 1,2-Benzoquinones p-Benzoquinones-o-Benzoquinones Benzoquinones Benzodiones Quinones 28.221732797588
600450 Glycolysis Cell-Based Assay Kit Exclusive New - 2011-08-18 96.256337006257 glycolysis-cell-based-assay-kit CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer 96.256337006257
10009231 HDAC1 (human recombinant) - >10% by SDS-PAGE 2006-12-06 49.189529278998 hdac1-human-recombinant Histone Deacetylase 1 HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 49.189529278998
10009377 HDAC2 (human recombinant) - >70% by SDS-PAGE 2006-12-06 33.099761843672 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 33.099761843672
10009232 HDAC3/NCOR2 (human recombinant) - ≥50% 2006-12-06 37.791079831831 hdac3-ncor2-human-recombinant Histone Deacetylase 3 HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 37.791079831831
10009379 HDAC5 (human recombinant) - >90% by SDS-PAGE 2006-12-06 34.210483294935 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 34.210483294935
16834 Hexadecanal-d5 - ≥99% deuterated compound 2009-03-02 66.062292817680 hexadecanal-d5 Palmitaldehyde; 16-Hexadecanal deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry 66.062292817680
10202 Hsp90α (human recombinant) - ≥80% 2010-03-16 4.436681575023 hsp90-human-recombinant Hsp86; Heat Shock Protein 90α heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a 4.436681575023
10342 Hsp90β (human recombinant) - ≥85% 2010-03-16 4.623776405590 hsp90-human-recombinant Hsc90; Hsp90 AB1; Heat Shock Protein 90β heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b 4.623776405590
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 2.253867403315 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 2.253867403315
13712 KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) - 2009-12-02 0E-12 kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated 0E-12
10010239 Kenpaullone 142273-20-9 >98% 2007-09-04 11.609281767956 kenpaullone NSC 664704; 9-Bromopaullone GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers 11.609281767956
9000332 Methylcarbamyl PAF C-8 Exclusive - ≥98% 2009-02-25 13.142127071823 methylcarbamyl-paf-c-8 Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF 13.142127071823
13208 Mirin 299953-00-7 ≥95% 2009-04-15 38.514751381215 mirin DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair 38.514751381215
13600 MK 0457 639089-54-6 ≥98% 2010-08-16 8.037817679558 mk-0457 Tozasertib; VX 680 mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C MK 0457 VX-680 VX680 Piperazines 8.037817679558
10009365 MTT Cell Proliferation Assay Kit - 2007-02-15 101.982154696132 mtt-cell-proliferation-assay-kit assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay cell based assay cba 101.982154696132
10011255 NSC 210902 51726-83-1 ≥95% 2008-09-15 4.363314917128 nsc-210902 Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 4.363314917128
13196 NSC 23766 (hydrochloride) 1177865-17-6 ≥98% 2010-07-20 20.106572539390 nsc-23766-hydrochloride 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration Aminoquinolines angiogenesis leukemia cancers gene expression Rac1 Inhibitor 20.106572539390
13303 NSC 663284 383907-43-5 ≥98% 2010-04-01 13.688296500920 nsc-663284 Cdc25 Phosphatase Inhibitor II; DA-3003-1 dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible 13.688296500920
18585 (−)-Nutlin-3 - ≥98% 2008-08-06 217.302905668099 -nutlin-3 Nutlin 3a P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a 217.302905668099
10009816 (+)-Nutlin-3 - ≥98% 2008-08-11 98.943698588091 -nutlin-3 Nutlin 3b p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b 98.943698588091
13641 NVP-AEW541 (hydrochloride) - 98% 2010-07-28 42.472298342541 nvp-aew541-hydrochloride 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 Pyrroles 42.472298342541
10010240 Olomoucine 101622-51-9 >98% 2007-09-13 11.274767166535 olomoucine inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle 11.274767166535
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 2.238987108655 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 2.238987108655
10735 Phthalazinone pyrazole Exclusive 880487-62-7 ≥98% 2011-07-27 2.014696132596 phthalazinone-pyrazole inhibitors inhibits inhibition auroras kinases cells cycle cancers centrosomes mitosis spindles cancers proliferation cells growth phosphorylation Auroroa-A Aurora-B Aurora-C A B C HCT116 HCT-116 Colo 116 HCT 116 Colo116 Colo-116 MCF7 MCF-7 MCF 7 2.014696132596
9000185 Prostaglandin A2 methyl ester Exclusive 31753-19-2 ≥98% 2010-11-08 1.263855125844 prostaglandin-a2-methyl-ester PGA2 methyl ester; Medullin methyl ester hypertension cancers lipophilic analogs PGA2 prostaglandins 1.263855125844
10011237 Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive - 2008-07-17 15.863112338858 protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion PP2A Cα; PP2A Δ309; PP2A L309 proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag 15.863112338858
10008394 PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) - >98% 2007-06-11 23.071255477233 ptdins-3-p1-1-2-dioctanoyl-sodium-salt Phosphatidylinositol-3-monophosphate C-8 (sodium salt); DOPI-3-P1 (sodium salt) phosphatidyl inositols IP3 diacylglcerol DAG PIP1 PIP2 PIP3 transuction C phospholipase D PLC PLD signaling signalling 23.071255477233
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% 2010-06-22 91.533093922651 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 91.533093922651
10009569 (R)-Roscovitine 186692-46-6 >98% 2007-09-04 12.728572744014 -r-roscovitine Seliciclib cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease 12.728572744014
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 190.471049723756 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 190.471049723756
13338 SU 6656 330161-87-0 ≥95% 2009-08-04 26.723723756906 su-6656 inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 26.723723756906
10574 Suberohydroxamic Acid 38937-66-5 ≥98% 2010-09-28 51.134732197667 suberohydroxamic-acid SBHA; Suberic bis-Hydroxamic Acid histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid Warner Lambert Brand of Mefenamic Acid Pharmascience Brand of Mefenamic Acid First Horizon Brand of Mefenamic Acid Parke Davis Brand of Mefenamic Acid Farmasierra Brand of Mefenamic Acid Ashbourne Brand of Mefenamic Acid Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid PMS Mefenamic Acid Acid Mefenaminic Mefenaminic Acid Acid Mefenamic Mefenamic Acid Forte Ponstan Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac 51.134732197667
13085 Tenovin-1 Exclusive 380315-80-0 ≥98% 2008-09-18 28.691767955801 tenovin-1 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma 28.691767955801
13086 Tenovin-6 1011557-82-6 ≥95% 2009-02-12 62.905509076559 tenovin-6 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs 62.905509076559
10011619 Terbinafine (hydrochloride) 78628-80-5 ≥98% 2010-02-16 4.016298342541 terbinafine-hydrochloride antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition Naphthalenes 4.016298342541
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 66.333977900552 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 66.333977900552
13791 TRF2 Polyclonal Antibody - 2010-06-24 0E-12 trf2-polyclonal-antibody TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis 0E-12
10011251 TWS119 601514-19-6 ≥90% 2008-12-11 14.932541436464 tws119 inhibitors inhibits inhibition stem cells differentiation neurogenesis neuron kinases GSK-3β GSK3β TWS 119 TWS-119 14.932541436464
13722 Ubiquitin Monoclonal Antibody (Clone 5B9-B3) - 2009-12-04 1.321657458563 ubiquitin-monoclonal-antibody-clone-5b9-b3 antibodies western blots WB blotting immunoblotting ELISA ubiquitination inhibitors proteins IκBα signal transduction 1.321657458563
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 41.226538697643 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 41.226538697643
13604 WYE-354 New 1062169-56-5 ≥98% 2012-01-12 89.187240638428 wye-354 mTOR mTORC1 mTORC2 inhibitors inhibits inhibition PI3K cancers cells growth PTENs tumors rapamycin complex 1 2 G1 phosphatidylinositol 3-kinase α PI3Kα kinases 89.187240638428
13576 YM-201636 371942-69-7 ≥95% 2010-04-14 6.829607734806 ym-201636 PIKfyve phosphoinositide kinase PIK zinc finger domains phosphatidylinositol 3-phosphate PI3P PI(3,5)P2 membrane trafficking cytoskeleton inhibitors endosomal trafficking endosomes phagocytosis retrovirus virology adipocytes insulin glucose diabetes YM201636 YM 201636 Aminopyridines 6.829607734806
13601 ZM 447439 331771-20-1 2010-08-03 3.193011049723 zm-447439 auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers Benzamides 3.193011049723
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?